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Abstract 
 
Background and Purpose—Computed tomographic perfusion (CTP) thresholds associated with 
follow-up brain infarction may differ by time from symptom onset to imaging and 
reperfusion.  We confirm CTP thresholds over time to imaging and reperfusion in acute ischemic 
stroke (AIS) patients from the HERMES data. 
Methods—Patients with occlusion on CT angiography were acutely imaged with CTP. Non-
contrast CT and MR-DWI at 24-48 hours defined follow-up infarction. Reperfusion was assessed 
on conventional angiogram. Tmax, cerebral blood flow (CBF), and cerebral blood volume (CBV) 
maps were derived from delay insensitive CTP post-processing. These parameters were analyzed 
using receiver operator characteristics to derive optimal thresholds based on time from stroke 
onset-to-CTP or to reperfusion. ANOVA and linear regression were used to test whether the 
derived CTP thresholds were different by time. 
Results—137 patients were included. Tmax thresholds of >15.7 s and >15.8 s and absolute CBF 
thresholds of <8.9 and <7.5 mL∙min−1∙100 g−1 for gray matter (GM) and white matter (WM) 
respectively were associated with infarct if reperfusion was achieved <90 min from CTP with 
stroke onset-to-CTP <180 min. The discriminative ability of CBV was modest. There were no 
statistically significant relationships between stroke onset-to-CTP time and Tmax, CBF, and CBV 
thresholds (all p>0.05). A statistically significant relationship was observed between CTP-to-
reperfusion time and the optimal thresholds for Tmax (p<0.001) and CBF (p<0.001). Similar but 
more modest relationship was noted for onset-to-reperfusion time and optimal thresholds for 
CBF (p<=0.01). 
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Conclusions—CTP thresholds based on stroke onset and imaging time and taking into account 
time needed for reperfusion may improve infarct prediction in patients with acute ischemic 
stroke. 
Key Words: Acute ischemic stroke, computed tomographic perfusion.  
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Recent trials have shown benefit of fast and effective endovascular treatment (EVT) in acute 
ischemic stroke (AIS) patients with intracranial occlusions.
1
 To help with triage and transport 
decisions as well as clinical decision making, physicians need to know how much brain tissue is 
likely to infarct by the time the patient reaches a tertiary center and endovascular therapy is 
administered. In a proof of principle analysis from an imaging cohort study, we showed that CTP 
thresholds estimating follow-up infarct depends on time from imaging to reperfusion.
2
 Here, we 
use data from recent positive endovascular trials obtained through the HERMES collaboration
1
 
to provide confirmatory evidence on time-dependent CTP thresholds that identify brain tissue 
that will likely infarct at different times from quality reperfusion.  
Methods 
Patients 
Data are from the HERMES Collaboration.
1
 The data that support the findings of this study are 
available from the corresponding author upon reasonable request. Subjects who had (1) baseline 
CTP imaging with >=8 cm z-axis coverage; (2) underwent EVT; (3) had reperfusion assessed on 
conventional angiography at end of EVT using the modified thrombolysis in cerebral infarction 
[mTICI]); and (4) had 24-hour follow-up imaging on MR DWI or non-contrast CT (NCCT) were 
included. All rials had ethics approval from institutional review boards.  Written informed 
consent was obtained from each patient. Each baseline CTP was processed by commercially 
available delay-insensitive deconvolution software (CT Perfusion 4D; GE Healthcare).  Details 
on image processing are described in the Supplemental Methods.  
Statistical Analysis 
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Differences between groups were tested using one-way analysis of variance (ANOVA) for 
parametric data, Kruskal–Wallis test for nonparametric data, and the Fisher’s test for categorical 
outcomes. Patients were stratified into 2 groups: (1) stroke onset-to-CTP <180 min and 
(2) >=180 min. These groups were then subdivided into 3 subgroups according to CTP-to-
reperfusion time: (1) <90 min reperfusion, (2) 90 to 180 min reperfusion, and (3) no acute 
reperfusion. CTP parameters (CBF, CBV, Tmax) from each subgroup were pooled for ROI-1 
(infarct on follow-up imaging) and ROI-2 (ipsilateral brain excluding infarct). Pooled data were 
then input into a logistic regression model to generate a receiver operating characteristic (ROC) 
for each parameter. ROC were analyzed to determine optimal CTP thresholds associated with 
follow-up infarction. The areas under the curves (AUC) of all CTP parameters were 
compared. Patient level data were analyzed in the same manner as pooled data to derive optimal 
CTP parameters at an individual level. Linear regression was used to determine the association 
between optimal CTP thresholds derived at the individual level and various interval times 
(continuous time analysis). Two-sided alpha <0.05 was considered statistically significant.  
Results 
137 patients receiving EVT were included (Supplemental Table I). Details of patients excluded 
are in Supplemental Results.  
In pooled analysis, for patients with onset-to-CTP <180 min (n=90), Tmax and CBF were better 
than CBV in predicting follow-up infarct in all three subgroups i.e. CTP-to-mTICI-2b/3 
reperfusion <90 min, 90 to 180 min, and no acute reperfusion. Similar findings were found for 
patients with onset-to-CTP >=180 min (n=47). Optimal Tmax, CBF, and CBV thresholds 
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associated with follow-up infarct from patient-level data analysis were similar. (Table 1 and 
Supplemental Table II) 
There was no statistically significant relationship between stroke onset-to-CTP time and the Tmax, 
CBF, and CBV thresholds (p>0.05). A statistically significant relationship was observed between 
CTP-to-reperfusion-time and optimal thresholds for Tmax (p<0.001 for continuous time analysis; 
r=-0.532 and -0.37 for GM and WM, respectively) and CBF (p<0.001 for continuous time 
analysis; r=0.445 and 0.579 for GM and WM, respectively. (Supplemental Figure II).  
When patients were stratified by onset-to-CTP time, a statistically significant relationship was 
observed between CTP-to-reperfusion-time and optimal CTP thresholds for patients with stroke 
onset-to-CTP <180 mins for Tmax (p<0.001; r=-0.644 and -0.433 for GM and WM, respectively) 
and CBF [p<0.001; r=0.545 and 0.736 for GM and WM, respectively]. Similar significant 
relationship between CTP-to-reperfusion-time and optimal thresholds for patients with stroke-
onset-to-CTP >=180 mins was noted for CBF [p=0.003; r=0.516 and p=0.04; r=0.406 for GM 
and WM, respectively], but not for the Tmax or CBV. (Figure 1) 
A statistically significant relationship was observed between stroke onset-to-reperfusion time and 
optimal thresholds for Tmax for GM (p<0.01; r=-0.277) and CBF [P=0.014; r=0.243 and p<0.01; 
r= 0.294 for GM and WM, respectively]. Tmax for WM and CBV did not show any significant 
differences in optimal thresholds (P>0.1).When patients were stratified by onset-to-CTP-time, a 
statistically significant relationship between onset-to-reperfusion-time and optimal thresholds 
was observed for patients presenting with onset-to-CTP <180 mins for Tmax (p<0.001; r=-0.477 
and p<0.01; r=-0.372 for GM and WM, respectively) and CBF (p<0.01; r=0.381 and p<0.01; 
0.546 for GM and WM, respectively). No statistically significant relationship was observed for 
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Tmax, CBF, CBV parameter for both GM and WM for the patients presenting with stroke-onset-
to-CTP>=180 mins. (Supplemental Figure III). 
Discussion 
Current perfusion paradigms use only one threshold (e.g. rCBF <30%) to estimate infarction in 
all patients.
3
 These results from the recent positive endovascular stroke trials however, provide 
confirmatory evidence that optimal perfusion thresholds (e.g. CBF) associated with infarction 
should progressively increase over time as infarcts grow into penumbra.
2, 4
 Unlike previous work 
that showed a relationship between optimal perfusion thresholds and imaging-to-reperfusion time, 
this analysis, more intuitively, shows that these thresholds are also dependent on onset-to-
reperfusion-time.
2
 
Interestingly, the association between optimal CTP thresholds and onset-to-reperfusion time was 
weaker when patients presented late. One reason could be that infarct growth over time may be 
slower amongst many late presenters, resulting in a weaker association between CTP thresholds 
estimating ischemic core and time-to-reperfusion. Another reason could be that patients with 
wake-up strokes present lat ; in such patients, stroke onset time is often imprecise.  These results 
also show that unlike CBF and Tmax, CBV is a sub-optimal CTP parameter for estimating 
ischemic core. Reasons include CBV being affected by time-density curve truncation and the fact 
that the relationship between severity of ischemia and CBV is non-linear.
2
  
This study has limitations. Differences between the deconvolution algorithm used in this analysis 
vs. other algorithms may affect Tmax. CBF thresholds that are used to estimate infarction should 
however be similar across algorithms. Second, only a proportion of follow up scans were DWI 
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images. Images with more precise follow up infarct delineation may improve the validity of 
these results.  
In conclusion, these results demonstrate that optimal CTP thresholds associated with follow-up 
infarction are dependent on time from stroke symptom onset to when quality reperfusion is likely 
to be achieved. In future, automated software that use perfusion to help physicians make 
treatment decisions should use variables such as time as model inputs when estimating infarction.  
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TABLES 
 
Table 1. Optimal CTP thresholds for infarction when reperfused<90 min, 90-to-180 min, and no 
acute reperfusion. 
Onset-to-
CTP 
Time(min) 
CTP-to- 
Reperfusion 
time(min) 
 
Tmax (s) CBF(mLmin-1 ∙100g-1) CBV(mL100g-1). 
GM WM GM WM GM WM 
<180 
<90(n=11) 
 
15.7 15.8 8.9 7.5 3.0 2.0 
AUC[95%CI] 0.93[0.91,0.95] 0.89[0.86,0.92] 0.92[0.89,0.95] 0.88[0.85,0.91] 0.61[0.59,0.63] 0.65[0.62,0.69] 
Sens,Spec 0.81,0.87 0.77,0.8 0.82,0.82 0.78,0.88 0.54,0.62 0.59,0.61 
90-180(n=44) 
 
12.0 11.0 11.5 10.4 3.0 1.7 
AUC[95%CI] 0.92[0.90,0.94] 0.88[0.86,0.90] 0.89[0.85,0.93] 0.91[0.89,0.93]* 0.74[0.71,0.77] 0.71[0.68,0.74] 
Sens,Spec 0.89,0.83 0.82,0.78 0.76,0.84 0.79,0.88 0.8,0.56 0.49,0.87 
No Acute 
Reperfusion(n=35) 
 
10.1 10.1 15.0 14.0 3.0 1.0 
AUC[95%CI] 0.90[0.88,0.92] 0.87[0.85,0.89] 0.92[0.90,0.94] 0.90[0.89,0.92]* 0.64[0.61,0.67] 0.62[0.60,0.64] 
Sens,Spec 0.84,0.76 0.78,0.75 0.81,0.83 0.77,0.9 0.57,0.64 0.57,0.63 
>180 
<90(n=9) 
 
13.7 13.8 9.2 8.0 2.0 2.0 
AUC[95%CI] 0.83[0.80,0.86] 0.82[0.77,0.87] 0.90[0.87,0.93]* 0.90[0.86,0.94]* 0.74[0.69,0.79] 0.67[0.63,0.71] 
Sens,Spec 0.77, 0.77 0.75,0.78 0.77,0.82 0.79,0.93 0.84,0.59 0.63,0.61 
90-180(n=19) 
 
11.7 11.8 14.2 12.5 3.0 2.0 
AUC[95%CI] 0.87[0.85,0.89] 0.86[0.84,0.88] 0.90[0.87,0.93] 0.87[0.85,0.89] 0.58[0.53,0.63] 0.55[0.51,0.59] 
Sens,Spec 0.77,0.76 0.76,0.76 0.83,0.79 0.72,0.81 0.49,0.64 0.52,0.58 
No Acute 
Reperfusion(n=19) 
 
10.0 10.0 15.4 14.4 3.8 2.7 
AUC[95%CI] 0.88[0.86,0.90] 0.88[0.86,0.90] 0.89[0.87,0.91] 0.85[0.82,0.88] 0.57[0.54,0.60] 0.62[0.59,0.65] 
Sens,Spec 0.82,0.75 0.8,0.76 0.78,0.81 0.82,0.7 0.45,0.65 0.63,0.54 
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Figure 1. Continuous-time analysis using patient level data for optimal computed tomographic 
perfusion (CTP) threshold associated with follow-up infarction versus CTP-to-reperfusion time 
in gray matter (A) and white matter (B). 
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